Trodelvy, a new breast cancer drug

A new drug for the treatment of a particular form of breast cancer. The marketing authorization application for Trodelvy is currently being assessed by Swissmedic and could be a game-changer for sufferers of so-called "triple-negative" breast cancer, a particularly aggressive form of the disease with no specific treatment to date.